These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7449528)

  • 1. Complement activation by iodinated contrast media.
    Hsieh KH; Chuang CM; Li SC; Lue HC; Lee TC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Jun; 13(2):115-20. PubMed ID: 7449528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complement activation after the intravascular administration of contrast media: a comparison between ionic and nonionic x-ray contrast media].
    Hoffmeister HM; Fuhrer G; Platten HP; Heller W
    Rofo; 1987 Dec; 147(6):673-5. PubMed ID: 2827265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the alternative pathway of the complement system by radiographic contrast media.
    Arroyave CM; Bhat KN; Crown R
    J Immunol; 1976 Nov; 117(5 Pt.2):1866-9. PubMed ID: 993582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].
    Böhm I; Speck U; Schild H
    Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total hemolytic complement (CH50) and its fractions C3 and C4 in the sera of patients with localized juvenile periodontitis.
    Anil S; Beena VT; Remani P; Mysore J; Vijayakumar T
    Ann Dent; 1993; 52(1):18-20. PubMed ID: 8323245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation following intravenous contrast material administration.
    Lieberman P; Siegle RL
    J Allergy Clin Immunol; 1979 Jul; 64(1):13-7. PubMed ID: 447947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement system activation by contrast media in neuroradiology.
    Gonsette RE
    Neuroradiology; 1978; 16():253-5. PubMed ID: 740185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 9. [Consumption hypocomplementemia: comparative value of haemolytic and protein estimations of the components of the classical pathway (author's transl)].
    Roncato M; Vial MC; Maillet F; Peltier A
    Nouv Presse Med; 1979 May; 8(20):1657-60. PubMed ID: 112575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of aortic reconstruction and collagen impregnation of Dacron prostheses on the complement system.
    De Mol Van Otterloo JC; Van Bockel JH; Ponfoort ED; Brommer EJ; Hermans J; Daha MR
    J Vasc Surg; 1992 Nov; 16(5):774-83. PubMed ID: 1433666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement components and activation in primary biliary cirrhosis.
    Lindgren S; Laurell AB; Eriksson S
    Hepatology; 1984; 4(1):9-14. PubMed ID: 6420306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease.
    Velosa J; Miller K; Michael AF
    Am J Pathol; 1976 Jul; 84(1):149-62. PubMed ID: 779494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
    Miyano A; Nakayama M; Fujita T; Kitajima H; Imai S; Shimizu A
    Diagn Clin Immunol; 1987; 5(2):86-90. PubMed ID: 3497734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
    Wouters D; Brouwer MC; Daha MR; Hack CE
    Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure.
    Seghaye MC; Duchateau J; Grabitz RG; Faymonville ML; Messmer BJ; Buro-Rathsmann K; von Bernuth G
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):978-87. PubMed ID: 8246580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemolytic complement in peripheral lymph of normal men.
    Olszewski WL; Engeset A
    Clin Exp Immunol; 1978 Jun; 32(3):392-8. PubMed ID: 99278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic complement in tears.
    Mondino BJ; Zaidman GW
    Ophthalmic Res; 1983; 15(4):208-11. PubMed ID: 6634056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of serum complement levels in cancer patients with progressing tumors.
    Verhaegen H; De Cock W; De Cree J; Verbruggen F
    Cancer; 1976 Oct; 38(4):1608-13. PubMed ID: 991081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.